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Transcriptional coregulators control the activity of
many transcription factors and are thought to have
wide-ranging effects on gene expression patterns.
We show here that muscle-specific loss of nuclear
receptor corepressor 1 (NCoR1) in mice leads to
enhanced exercise endurance due to an increase of
both muscle mass and of mitochondrial number
and activity. The activation of selected transcription
factors that control muscle function, such as MEF2,
PPARb/d, and ERRs, underpins these phenotypic
alterations. NCoR1 levels are decreased in condi-
tions that require fat oxidation, resetting transcrip-
tional programs to boost oxidative metabolism.
Knockdown of gei-8, the sole C. elegans NCoR
homolog, also robustly increased muscle mitochon-
dria and respiration, suggesting conservation of
NCoR1 function. Collectively, our data suggest that
NCoR1 plays an adaptive role in muscle physiology
and that interference with NCoR1 action could be
used to improve muscle function.
INTRODUCTION
Transcription factors are key mediators in homeostatic circuits,
as they process environmental signals into transcriptional
changes (Desvergne et al., 2006; Francis et al., 2003). Transcrip-
tional coregulators have recently emerged as equally important
modulators of such adaptive transcriptional responses. The
fact that the activity of coactivators and corepressors is tightly
regulated through the spatial and temporal control of their
expression and activity levels opens another avenue to adapt
transcription to environmental cues (Feige and Auwerx, 2007;
Rosenfeld et al., 2006; Smith and O’Malley, 2004; Spiegelman
and Heinrich, 2004). Interestingly, many of these coregulators
do not operate in isolation but are part of large multiproteincomplexes that integrate complex signaling pathways. The
convergence of an elaborate coregulator network on the perox-
isome proliferator-activated receptor (PPAR) coactivator
a (PGC)-1a illustrates this principle well, as its activity depends
on several other coregulators, including the steroid receptor
coactivators, NR-interacting protein 1 or RIP140, CREB-binding
protein, p300, protein arginine methyltransferase 1, general
control of amino acid synthesis 5, and SIRT1 (Fernandez-Marcos
and Auwerx, 2011; Handschin and Spiegelman, 2006).
The corepressor (NCoR1) and the silencing mediator for reti-
noid and thyroid hormone receptor (SMRT or NCoR2) are also
acting as cofactor scaffolding platforms. NCoR1 and SMRT
hardwire corepressor pathways that incorporate several deace-
tylases (including class I [HDAC3], class II [HDAC4, 5, 7, and 9],
and class III [SIRT1] HDACs), transducin beta-like 1 (TBL1) and
TBLR1, two highly related F box/WD40-containing factors, and
the G protein pathway suppressor 2 (reviewed in Perissi et al.,
2010). Because germline NCoR1/ and SMRT/ mice are
embryonically lethal (Jepsen et al., 2000, 2007), information on
the role of these proteins in adult physiology is limited. Studies
of mice with mutations in the NR interaction domains (RIDs) 1
and 2 of SMRT (SMRTmRID), which solely disrupts its interaction
with NRs, indicated that lethality of SMRT/ mice is caused by
non-NR transcription factors (Nofsinger et al., 2008). Work in
3T3-L1 cells in which NCoR1 or SMRT expression was reduced
by RNA interference demonstrated that they repress adipogen-
esis by inhibiting PPARg (Yu et al., 2005). In line with this, adipo-
genesis was enhanced in mouse embryonic fibroblasts (MEFs)
from SMRTmRID mice (Nofsinger et al., 2008). Interestingly,
SIRT1 is also part of the NCoR1/SMRT complex and contributes
to the inhibition of PPARg (Picard et al., 2004).
Contrary to adipose tissue, the function of NCoR1/SMRT in
skeletal muscle has not yet been established. We here report
the generation and characterization of muscle-specific
NCoR1/ (NCoR1skm/) mice, which displayed a remarkable
enhanced exercise capacity. This was the result of increased
musclemass and amuscle fiber type shift towardmore oxidative
fibers, coordinated by the induction of genes involved in mito-
chondrial biogenesis and function, ensuing from the activationCell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 827
Figure 1. Validation and Metabolic Phenotypes of NCoR1skm/ Mice
(A) mRNA levels of NCoR1 and Smrt in different tissues were determined by qRT-PCR. Values were normalized to 36B4. n = 8–10/group.
(B) Biochemical analysis of the plasma from NCoR1skm+/+ and skm/ mice after 6 hr fasting (n = 8) either on chow diet (CD) (top) or HFD (bottom).
(C) Circadian activity, measured as the total locomotor activity, and energy expenditure were evaluated by themeasurement of oxygen consumption (VO2) and by
the calculation of the respiratory exchange ratio (RER) over a 24 hr period after 12 weeks of HFD. The bar graphs represent the average for each group. n = 12.
(D) Body temperature was measured for 7 hr in mice exposed to 4C after 18 weeks of HFD. n = 7–8.
(E and F) Exercise experiments, measuring running time and distance until exhaustion (endurance exercise) (E) and the increment of VO2max during exercise and
RER levels at basal and VO2max condition (F) were performed after 14 and 17 weeks HFD.
Data are expressed as mean ± SEM. See also Figures S1–S3 and Tables S1–S3.of PPARb/d, the estrogen-related receptors (ERRs), and myo-
cyte-specific enhancer factor 2 (MEF2). Worms with a muscle-
selective knockdown of gei-8, the sole C. elegans NCoR
homolog, also had improved mitochondrial activity. These data
combined with the specific reduction in the expression levels
of NCoR1, but not SMRT, in situations of enhanced fat oxidation
establish NCoR1 as a key physiological regulator of muscle
mass and function.
RESULTS
NCoR1skm/ Mice Have Increased Muscle Mass
Given the embryonic lethality of germline NCoR1/ mice (Jep-
sen et al., 2000) (Table S1 available online), we generated a floxed
NCoR1 mouse line in which exon 11 of the NCoR1 gene (Ho¨rlein
et al., 1995) was flanked with LoxP sites, priming it for subse-
quent deletion using the Cre-LoxP system. These mice, bearing
floxed NCoR1 L2 alleles, were then bred with a skeletal muscle828 Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc.(skm)-specific Cre driver (human a-skeletal actin promoter) (Min-
iou et al., 1999) to yield NCoR1skm/ and NCoR1skm+/+ mice
(Figure S1). As expected, NCoR1 mRNA expression was signif-
icantly decreased in soleus, gastrocnemius, and quadriceps
and modestly reduced in the heart muscle of NCoR1skm/
mice, but not altered in other tissues (Figure 1A). No compensa-
tory induction of the related corepressor SMRT/NCoR2 (Chen
and Evans, 1995) was observed (Figure 1A). We also tried to
determine NCoR1 protein levels in muscle but failed to detect
the endogenous protein with the currently available NCoR1
antibodies.
NCoR1skm/ mice were indistinguishable from NCoR1skm+/+
mice upon visual inspection, and no gross organ anomalies
were revealed upon autopsy. The relative mass of the soleus
muscle was higher, whereas the mass of the gastrocnemius
showed a trend toward an increase, which did not reach statis-
tical significance (Figures S2A and S2B). The soleus was also
more intensely red, and there were larger sections with reddish
color in the gastrocnemius in NCoR1skm/ mice (Figure S2C).
Body weight evolution and food intake of male NCoR1skm/
and NCoR1skm+/+ mice after weaning were comparable both
on chow diet (CD) and on high-fat diet (HFD) (Figure S2A and
data not shown). On CD, carbohydrate and lipid profiles were
similar except for LDL cholesterol, which was reduced in
NCoR1skm/ mice (Figure 1B). In addition to the lower LDL
cholesterol on CD, total and HDL cholesterol levels were also
reduced in NCoR1skm/mice on HFD (Figure 1B). Furthermore,
glucose edged down (p = 0.074) in the wake of similar insulin
levels on HFD. The slightly reduced area under the curve in
intraperitoneal glucose tolerance test (IPGTT; Figure S2D) and
the delayed recovery from hypoglycemia during intraperitoneal
insulin tolerance test (IPITT; Figure S2E) in mutant mice on
HFD may suggest a discrete improvement in insulin sensitivity
but without a clear impact on glucose tolerance.
Enhanced Exercise Performance in NCoR1skm/ Mice
We next evaluated energy expenditure by indirect calorimetry
and actiometry in CD- and HFD-fed mice (Figures 1C and
S2F). Total locomotor activity was significantly higher in
NCoR1skm/ mice. Consistent with this, O2 consumption (VO2)
was increased under both CD and HFD. Interestingly, the
NCoR1skm/ mice displayed a marked decrease in the respira-
tory exchange ratio (RER) on a HFD (Figure 1C), indicating an
enhanced use of fat as a main energy source. NCoR1skm/
mice were also more cold tolerant, as they maintained their
body temperature better when exposed to 4C (Figure 1D).
Exercise performance was strikingly improved in
NCoR1skm/mice (Figures 1E, 1F, and S3A–S3D). In endurance
exercises, NCoR1skm/ mice ran for a significantly longer time
and distance before exhaustion (Figures 1E, S3A, and S3B).
The increase of the VO2 values (DVO2) during exercise and the
maximal ability to utilize oxygen during exercise (VO2max), which
critically determines the endurance performance of skeletal
muscle, was slightly higher in NCoR1skm/ mice on both CD
(Figure S3D and data not shown) and HFD (Figure 1F). Despite
the moderate reduction in NCoR1 mRNA levels in cardiac
muscle of NCoR1skm/ mice, heart rate, blood pressure,
cardiac morphology, and function were not changed (Figures
S3E–S3G and Table S2).
NCoR1skm/ Muscle Demonstrates Increased
Oxidative Capacity
The enhanced exercise capacity, associated with the increase in
overall musclemass and change inmuscle appearance, led us to
examinemusclemorphology. Upon stainingmuscles with hema-
toxylin/eosin or toluidine blue, not only was the diameter of single
muscle fibers larger, but also the connective tissue between
muscle bundles was less abundant in NCoR1skm/ mice
(Figures 2A, 2B, and S4A). The increased number of intensely
stained fibers upon succinate dehydrogenase (SDH) and cyto-
chrome oxidase (COX) (Figures 2C and 2D) staining further testi-
fied to increased mitochondrial activity in the NCoR1skm/
gastrocnemius. Two mitochondrial DNA markers, cyclooxyge-
nase 2 (Cox2) and 16S ribosomal RNA, normalized by genomic
DNA markers (uncoupling protein 2 [Ucp2] and hexokinase 2
[Hk2]) were both significantly higher in NCoR1skm/ muscle,indicative of increased mitochondrial content (Figure 3B). This
observation was also underscored by electron microscopy,
which revealed more abundant and larger mitochondria with
normal structure (Figure 3A). Immunohistochemical analysis of
the myosin heavy-chain (MyHC) isoforms (Schiaffino et al.,
1989) demonstrated a decreased number of the more glycolytic
MyHC2b fibers, with a concomitant increase in the number of
more oxidative MyHC2x and 2a fibers in the NCoR1skm/
gastrocnemius (Figure 3C). This observation was consolidated
by analysis of MyHC isoform mRNAs, which indicated an
increased expression of the mRNAs of MyHC2x and 2a (more
oxidative fibers) compared to that of MyHC2b (more glycolytic)
in bothNCoR1skm/ gastrocnemius and quadriceps (Figure 3D).
In quadriceps, but not gastrocnemius, the expression ofMyHC1
mRNA was also increased. Finally, staining of platelet-endothe-
lial cell adhesionmolecule (PECAM)-1, an endothelial cell marker
of angiogenesis and tissue vascularization that contributes to
enhanced myocellular aerobic capacity, also increased in
NCoR1skm/ muscle (Figure S5C).
The Control of Muscle Mitochondria by NCoR1
Is Conserved in C. elegans
To investigate whether the effects of NCoR1 deficiency are
evolutionary conserved, we took advantage of the power of
C. elegans genetics. A protein blast search indicated that GEX-
interacting protein family member 8 (gei-8) is the only putative
NCoR1 homolog in the C. elegans genome. Further analysis
showed that the total amino acid sequence of gei-8 is 43%
homologous to mouse NCoR1 and contained conserved SANT
(switching-defective protein 3 [Swi3], adaptor 2 [Ada2], nuclear
receptor corepressor [N-CoR], transcription factor [TF] IIIB)
domains (34% identical/77% similar for SANT1; 20% identical/
57% similar for SANT2) (Figure 3E). Other important functional
domains (repressor domain [RD] and nuclear receptor interac-
tion domain [ID]) were also conserved (Figure 3E). Upon the
robust gei-8 knockdown in worms expressing a mitochondrial
GFP reporter driven by the muscle-specific myo-3 promoter,
a striking enlargement of the mitochondria was observed in
body wall muscle (Figure 3F). This result is not due to an indirect
effect on transcriptional activity through the myo-3 promoter
because no increase in GFP expression is observed with another
strain carrying the pmyo-3::GFP reporter (Figure S4B). We also
measured O2 consumption in NR350 transgenic worms fed
with gei-8 dsRNA. NR350 worms lack rde-1, an essential
component of the RNAi machinery encoding a member of the
PIWI/STING/Argonaute family, in all tissues except the body
wall muscle in which the wild-type rde-1 gene has been rescued
using the hlh-1 promoter (Durieux et al., 2011). Consistent with
the effects observed in the mouse, also the muscle-specific
knockdown of gei-8 enhanced O2 consumption in these
NR350 worms (Figure 3G), suggesting that the function of
gei-8 to control mitochondrial metabolism is conserved through
evolution.
NCoR1 Negatively Correlates with Key Mitochondrial
and Myogenic Genes
After establishing these striking mitochondrial effects of NCoR1
in mice and worms, we exploited a complementary systemsCell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 829
Figure 2. Histological Analyses of the Muscles of Control and NCoR1skm/ Mice
(A) Histological analysis of gastrocnemius sections stained with hematoxylin and eosin.
(B) Distribution and mean diameter of muscle fibers in gastrocnemius and soleus.
(C and D) Histological analysis of gastrocnemius and soleus sections by succinate dehydrogenase (C) and cytochrome C oxidase staining (D). S, soleus; G,
gastrocnemius. The ratio of the stained fibers is indicated in the graph.
Data are expressed as mean ± SEM. See also Figure S4.genetics approach to evaluate NCoR1s molecular coexpression
partners in the mouse (Argmann et al., 2005; Houtkooper et al.,
2010). Expression of NCoR1 in two panels of genetically
heterogeneous mice, made by intercrossing C57BL/6 with
C3H/HeJ (the B3H F2 cross) or C57BL/6 with DBA/2J (the B3
D genetic reference population) mice, varied ± 1.5-fold between
cases in both lung and muscle (Figure 4A). A large number of
transcripts covaried significantly with NCoR1 in the different
mice lines belonging either to the B3H cross or B3D strains.
Most distinctively, only a fraction of these covariates were
negative, which was against the dogma expected for a core-
pressor such as NCoR1s (Tables S4 and S5). In skeletal muscle
from the B3H cross (n = 124 females), strong covariates of
NCoR1 include Mef2d, myoglobin (Mb), muscle creatine kinase
(Mck), and glucose transporter type 4 (Glut4) (van Nas et al.,
2010). A similar analysis of lung tissue from the B3D cross
(n = 51 strains) includes genes such as cytochrome c (Cycs),
citrate synthase (Cs), pyruvate dehydrogenase kinase 4 (Pdk4),
uncoupling protein 3 (Ucp3), vascular endothelial growth factor
b (Vegfb), and long-chain acyl-CoA dehydrogenase (Lcad)
(Alberts et al., 2011) (Figure 4B and Tables S4 and S5). This
analysis significantly extends the number of NCoR1 targets830 Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc.and covariates, with several of them being consistent with
increased mass and mitochondrial biogenesis observed in
NCoR1skm/ muscle.
This initial set of NCoR1 covariates (Figure 4B) was then
included together with other potential candidates for qRT-PCR
analysis in mixed fiber muscle, including the gastrocnemius
and quadriceps (Figures 4C and S5A and data not shown).
Whereas the mRNAs of most relevant NRs were unchanged,
mRNA levels of PGC-1a and b (Ppargc1a and 1b) increased.
Several genes involved in mitochondrial function, including
those encoding for proteins involved in TCA cycle and oxidative
phosphorylation (Cs, cytochrome c oxidase subunit IV [CoxIV],
Pdk4), uncoupling (Ucp2 and Ucp3), fatty acid uptake, and
metabolism (Cd36 and Lcad), were robustly induced in
NCoR1skm/ muscle. In addition, mRNA levels of Vegfb and
its receptor Flt1, which regulates trans-endothelial fatty acid
transport (Hagberg et al., 2010), were also induced. Interestingly,
the expression of hypoxia-inducible factor (Hif) 1a and of its
targets, glucose transporter 1 (Glut1), fibroblast growth factor
(Fgf), and Fgf-receptor 2 (Fgfr2), were unchanged (Figure S5A),
whereas all three Vegfa isoforms, i.e., Vegfa-121, -165, and
-189, were induced in NCoR1/ quadriceps, gastrocnemius,
Figure 3. Histological Analyses of the Muscles of Mice and C. elegans
(A) Transmission electron microscopy of nonoxidative fibers of NCoR1skm+/+ and skm/ gastrocnemius. M, mitochondria.
(B) Relative mitochondrial DNA content (Cox2 or 16S) in gastrocnemius was measured and normalized by genomic DNA content (Ucp2 and Hk). n = 6.
(C) Representative MyHC1, 2a, and 2b immunohistochemical detection on serial sections of the soleus and gastrocnemius.
(D) Subtypes of MyHCs in gastrocnemius and quadriceps were analyzed by qRT-PCR in NCoR1skm+/+ and skm/ mice. n = 6.
(E) Identity/similarity (%) in the sequences of gei-8withmammalian NCoR1. Multiple alignments of SANT domains of NCoR1 homologs. Color identifies similarity.
(F) Representative pictures of the effects of RNAi-mediated knockdown of gei-8 on mitochondrial morphology and number in a C. elegans strain carrying
a mitochondrial GFP reporter driven by the muscle-specific myo-3 promoter (left). Quantification of the mitochondrial induction by fluorescence upon gei-8
knockdown (middle) and of the efficacy of the RNAi-mediated gei-8 knockdown by qRT-PCR analysis (right).
(G) Muscle-specific RNAi inhibition of gei-8 enhances respiration in C. elegans.
Data are expressed as mean ± SEM. See also Figure S4 and Tables S2 and S3.and soleus (Figures 4C and 5B). Together with this increase
in Vegfa, both Angpt2 and Pdgfb mRNA levels were induced
(Figure 4C), suggesting that myocellular aerobic capacity is
facilitated by an HIF1a-independent angiogenic pathway in
NCoR1skm/ mice (Arany et al., 2008).
Enhanced PPARb/d and/or ERR Function
in NCoR1skm/ Muscle
Several genes whose expression is changed in the absence of
NCoR1 are PPARb/d and/or ERR targets (Figure 4). Because
the expression of PPARb/d and/or ERR was unchanged in
NCoR1skm/ mice (Figure S5A), a direct effect of NCoR1 on
the expression of these targets through the activation of these
NRs was expected. As cases in point to demonstrate the
recruitment of NCoR1 to these genes, we selected the mouseUcp3 and Pdk4 promoters, which contain three PPAR
responsive elements (PPREs) (Figure 5A) and extended NR
half-sites (NR1/2), known to bind members of the ERR
subfamily (Figure 5E) (Zhang et al., 2006), respectively. We
first used NIH 3T3 cells in which an epitope-tagged version
of NCoR1 (NCoR1-FLAG) was expressed. The two PPREs
adjacent to the Ucp3 transcription start site recruited
NCoR1 more efficiently, compared to two control sequences
in the Gapdh and Ucp3 promoter that lack PPREs (Figure 5B,
left). Likewise, NCoR1 bound avidly to the mouse Pdk4
promoter NR1/2 site in transfected NIH 3T3 cells (Figure 5F,
left). Although there is a two nucleotide difference in NR1/2
site of the human Pdk4 promoter (Figure 5E), NCoR1 and
ERRa were also recruited to this site in human HEK293 cells
(Figure 5H).Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 831
Figure 4. Identification of NcoR1-Correlated Genes
(A) Expression of NCoR1 mRNA in lung tissue of the different B3D strains (top) and in muscle tissue from an F2 intercross between C57BL/6J and C3H/HeJ
(bottom). Natural expression variation across the animals is 1.5-fold in each tissue.
(B) Pearson’s r and Spearman’s rank correlation coefficient, rho, were calculated with corresponding p values for the mRNA covariation between NCoR1 and
genes involved in oxidative phosphorylation (Cycs, Cs, and Pdk4), mitochondrial uncoupling (Ucp3), fatty acid metabolism (Lcad), angiogenesis (Vegfb), glucose
uptake (Glut4), and myogenesis (Mef2d, Mb, and Mck). The tissue from which data were generated is indicated.
(C) Gene expression analysis by qRT-PCR in NCoR1skm+/+ and skm/ gastrocnemius. n = 10.
Data are expressed as mean ± SEM. See also Figures S5 and S6 and Tables S3–S5.We then used a highly specific NCoR1 antibody, which we
recently generated (G.D.B. and R.M.E., unpublished data),
for ChIP experiments in C2C12 myotubes. Confirming our data
in NIH 3T3 cells that express NCoR1-FLAG, endogenous
NCoR1 occupied the same Ucp3 PPREs (Figure 5B, right). The
recruitment of NCoR1 to the Ucp3 promoter was robustly
inhibited by the addition of the selective PPARb/d ligand
GW501516. Likewise, endogenous NCoR1 was readily detected
on the NR1/2 in the Pdk4 promoter in C2C12 myotubes (Fig-
ure 5F, right).
Subsequently, we explored whether NCoR1 gene deletion in
NCoR1L2/L2 MEFs by means of adenoviral Cre recombination,
or NCoR1 gene knockdown in C2C12 myotubes infected by
an NCoR1 shRNA adenovirus, modulates histone H4 acetylation
on the Ucp3 and Pdk4 promoters. Consistent with NCoR1
binding to these promoters in NIH 3T3 cells and C2C12 myo-832 Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc.tubes (Figures 5B and 5F), NCoR1 deletion or silencing induced
H4 acetylation of both target promoters in MEFs and C2C12
cells, indicating chromatin opening (Figures 5C and 5G).
To further consolidate these observations, we analyzed
whether NCoR1 interacts directly with PPARb/d or ERRa, using
nuclear extracts of HEK293 cells, transfected with tagged
versions of NCoR1, PPARb/d, or ERRa. Although a specific
association between NCoR1 and PPARb/d was evident in these
co-IP experiments (Figure 5D, lane 8), we failed to detect a similar
interaction between ERRa and NCoR1 (data not shown).
MEF2 Is Hyperacetylated and Activated
in the Absence of NCoR1
The increasedmusclemass observed inNCoR1skm/mice indi-
cated that the absence of NCoR1 not only induced oxidative
metabolism, but also stimulated myogenesis. In line with this,
Figure 5. Increased PPARb/d and ERR Activity in NCoR1skm/ Muscle
(A, B, E, F, and H) NCoR1 recruitment to the PPREs on mouse Ucp3 promoter (B) and to the ERR-RE on human (H) and mouse (F) Pdk4 promoter determined by
ChIP in NIH 3T3 cells transfected with an NCoR1-FLAG vector or in C2C12 myotubes. A schematic of the promoters of the Ucp3 (A) and Pdk4 (E) genes and the
sequence alignment of the mouse, rat, and human Pdk4 promoter is also shown to highlight the conservation of the NR1/2 (or ERR-RE) (E). Boxes indicate
putative PPREs in the Ucp3 and the NR1/2, IRS, and Sp1 in the Pdk4 promoter. ChIP experiments for the Ucp3 promoter were performed in C2C12 myotubes
both before and 6 hr after addition of a PPARb/d agonist (100 nM GW501516). #, not detected. ChIP experiments in HEK293 cells transfected with FLAG-NCoR1
and HA-ERRa vector (H).
(C and G) Binding of acetylated histone 4 (H4) to the PPREs on the Ucp3 and to the NR1/2 on the Pdk4 promoters in ChIP assays, using either immortalized
NCoR1L2/L2 MEFs, infected with an adenovirus either expressing GFP or Cre recombinase, or C2C12 myotubes infected with the Ad-shNCoR1 virus. Repre-
sentative data are shown from three experiments.
(D) Interaction between PPARb/d and NCoR1 determined by in vitro co-IP experiments from HEK293 cells in which NCoR1-FLAG and/or V5-PPARb/d are
expressed. IP was performedwith control IgG (lanes 1, 3, 5, and 7) or anti-FLAG antibody (lanes 2, 4, 6, and 8), and the immunoblot was developed with an anti-V5
antibody. PPARb/d coimmunoprecipitated by the anti-FLAG antibody is indicated by an arrow. Input samples are shown in lanes 912.
Data are expressed as mean ± SEM. See also Figure S6.mRNA levels of two markers of myogenesis, Mb and Mck, were
increased in NCoR1skm/ quadriceps (Figure 6A). Among
several myogenic regulatory factors, only the expression of
two Mef2 family members, i.e., Mef2c and Mef2d, negatively
correlated with NCoR1 expression in our systems genetics
analysis (Figures 4 and S6A). The selective induction of Mef2c
and Mef2d mRNA was furthermore confirmed by qRT-PCR of
NCoR1skm/ gastrocnemius and quadriceps, whereas nochanges were found in MyoD, Myf5, and myogenin mRNA
(Figures 6A and S6E and data not shown).
The activity of MEF2 family members is not only controlled by
their expression levels, but is also modulated by their acetylation
status. MEF2 is acetylated and activated by p300, whereas it is
deacetylated by HDAC3 and HDAC4, which are part of the
NCoR1 corepressor complex (Ma et al., 2005; Nebbioso et al.,
2009). Because the expression of the Mef2d isoform is mostCell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 833
Figure 6. Enhanced MEF2 Activity in NCoR1skm/ Muscle
(A) Gene expression of myogenesis-related genes was measured by qRT-PCR in NCoR1skm+/+ and skm/ quadriceps. n = 10.
(B–D) Acetylation levels of MEF2Dwere determined by western blot after immunoprecipitation with an Ac-Lys Ab from gastrocnemius (B), fromNCoR1L2/L2MEFs
infected with Ad-GFP or Ad-Cre recombinase (C, right), and from C2C12 myotubes infected with Ad-shLacZ or Ad-shNCoR1 (D). MEF2D expression in total
protein extracts was shown in the bottom panels. The expression of NCoR1 and actin in NCoR1L2/L2 MEFs was also shown (C, left).
(E) MEF2 target mRNAs determined by qRT-PCR in C2C12 myotubes infected with either Ad-shLacZ or Ad-shNCoR1. n = 6.
(F) NCoR1 recruitment to the MEF2 site of the mouse Mb promoter determined by ChIP in C2C12 myotubes.
(G) Binding of either global acetylated histone 4 (H4) or H4 acetylated on K16 (H4K16) to the MEF2 site of the Mb gene was evaluated by ChIP from C2C12
myotubes infected as in (E).
Data are expressed as mean ± SEM. See also Figure S6 and Table S3.prominently correlated with NCoR1 expression, we investi-
gated MEF2D acetylation in gastrocnemius and found that
its acetylation levels were enhanced in NCoR1skm/ mice (Fig-
ures 6A and 6B).
We then compared the acetylation of MEF2D in floxed
NCoR1L2/L2MEFs, infected with an adenovirus expressing either
GFP as control or Cre-recombinase to reduce NCoR1 protein
expression (Figure 6C, left). Whereas MEF2D protein levels
were stable in NCoR1/ MEFs, perhaps due to the more acute
nature of the deletion, MEF2D was robustly hyperacetylated
when NCoR1 levels were attenuated (Figure 6C, right). Likewise,
a slight but consistent MEF2D hyperacetylation was observed
in C2C12 myotubes infected with Ad-shNCoR1 to knock down834 Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc.NCoR1 expression (Figures 6D and S6B–S6D), further under-
scoring the importance of MEF2D deacetylation by the NCoR1
complex.
Given the induction of MEF2D expression and its hyperacety-
lation and consistent with our systems genetics analysis (Fig-
ure 4B), mRNA levels of the MEF2 targets, Mb and Mck, were
robustly induced in NCoR1skm/ gastrocnemius (Figure 6A).
Silencing ofNCoR1 in C2C12 myotubes also resulted in a similar
induction of several MEF2 target genes, including Mb, Mck,
Glut4, c-Jun, Nur77, PGC-1a, and PGC-1b (Figures 6E and
S6B–S6D). In line with these data, endogenous NCoR1 was
readily detected on MEF2-binding sites on these target
promoters in C2C12 myotubes, as illustrated for the Mb
promoter (Figure 6F). The induction of these MEF2 targets by
NCoR1 knockdown was furthermore accompanied by H4K16
and global H4 hyperacetylation on their promoters (e.g., Mb,
Glut4, and Mck) (Figures 6G and S6F).
NCoR1 Levels Are Regulated in Response
to Physiological Stimuli
We next investigated whether NCoR1 function could be altered
by different physiological stimuli in vitro and in vivo. One hour
after stimulation of 293T cells with 1 mM insulin, higher amounts
of endogenous NCoR1 (Figure 7A) or transfected FLAG-NCoR1
(Figure S7A) were detected in nuclei, as evidenced by immuno-
fluorescence and subcellular fractionation (Figures 7A–7C).
At the transcriptional level, NCoR1 mRNA changed in
response to different concentrations of glucose in the culture
media (Figures 7D and 7E). Growing MEFs in low glucose
decreased NCoR1 mRNA (Figure 7D) and protein (Figure 7E)
levels, concomitant with the induction of its target genes
(Pdk4, Vgefb, Mef2d, etc.). Similar results, i.e., decreased
mRNA levels of NCoR1 associated with increased expression
of its targets (Pdk4, Ucp2, Ucp3, Vegfb, Mb, Mck, and Glut4)
were also obtained in glucose-deprived C2C12 myotubes (Fig-
ure S7B). Interestingly, the reduction of glucose decreased
mRNA levels of NCoR1, but not those of SMRT (Figure 7F).
The tight dose-dependent correlation between NCoR1 expres-
sion and glucose levels in the culture medium (Figures 7E and
7F) suggested the possibility that NCoR1 could block the oxida-
tion of lipid substrates when glucose was available. We therefore
evaluated NCoR1 mRNA and protein in MEFs cultured in
different fatty acid concentrations (Figure 7H and 7I). The addi-
tion of oleic acid (OA) to the medium to force fatty acid oxidation
also decreased NCoR1 levels, independently of the glucose
concentration (Figure 7H). These effects seemed again specific
to NCoR1, as only a small difference in SMRT mRNA levels
was observed with OA in the absence of glucose (data not
shown). Together, these data indicate that settings that favor
fatty acid oxidation (i.e., low glucose, low insulin, and high fatty
acid) are all associated with a reduction of NCoR1.
We then tested whether different conditions that enhance fatty
acid oxidation also modulate NCoR1mRNA levels in the muscle
in vivo. This was indeed the case, as muscle NCoR1, but not
SMRT, mRNA levels decreased after exercise (3 hr after a resis-
tance run), high-fat feeding (20 weeks of high fat feeding), fasting
(after a 16 hr fast), and aging (6-month-old versus 2-year-old
mice) (Figure 7J and data not shown). Interestingly, the reduction
inNCoR1mRNA levels matches well with the potentiation of lipid
oxidation after exercise (Kiens and Richter, 1998; Pilegaard
et al., 2000), high-fat feeding (Watanabe et al., 2006), and fasting
(Storlien et al., 2004) and in aged mice (Houtkooper et al., 2011).
Also in epididymal white adipose tissue, HFD feeding reduced
specifically NCoR1, and not SMRT, mRNA (Figure S7C). Unlike
for the muscle, where we were unable to detect NCoR1 with
the available antibodies, NCoR1 protein levels almost disap-
peared from epididymal fat upon HFD (Figure S7D). Altogether,
these data led us to suggest that NCoR1 is a negative transcrip-
tional regulator of fatty acid oxidation and that a reduction of
NCoR1 enables themuscle (and adipose tissue) to deal with lipid
substrates more efficiently.DISCUSSION
The increased muscle mass, associated with a strikingly
improved exercise capacity, is the most prominent phenotypic
outcome of the muscle-specific NCoR1 gene deletion. The
enhanced exercise capacity is associated with a reprogramming
of glycolytic tomore oxidativemuscle fibers and a corresponding
stimulation of oxidative mitochondrial metabolism, indicative of
an improved intrinsic quality of the muscles. The increased
muscle quantity and oxidative profile in NCoR1skm/ mice
also contribute to the slight improvement in metabolic parame-
ters after high-fat feeding and to the cold resistance subsequent
to shivering thermogenesis (Canto´ and Auwerx, 2009).
Combined, these properties suggest that NCoR1 acts as
a master modulator of mitochondrial metabolism in the muscle,
a hypothesis bolstered by the fact that the inhibition of the single
worm NCoR homolog, gei-8, also robustly boosts muscle oxida-
tive mitochondrial metabolism in C. elegans. The evolutionary
conservation of the structure and function of this corepressor
makes it tempting to speculate that NCoR may have evolved
to facilitate metabolic adaptation of the mitochondria to energy
availability, as has been described for other cofactors as SIRT1
(Canto´ and Auwerx, 2009).
As to how the absence of NCoR1 in themuscle achieves these
remarkable effects, it is important to recall that NCoR1 docks
histone deacetylases, such as HDAC3 (Alenghat et al., 2008)
and SIRT1 (Picard et al., 2004). The use of mice with a point
mutation in the NCoR1 deacetylase activation domain, incapaci-
tating its interaction with HDAC3, indicated that this interaction is
a nodal point in epigenetic regulation (Alenghat et al., 2008; Feng
et al., 2011). The physiological alterations in the NCoR1skm/
muscle together with the study of the expression correlates of
NCoR1 suggested that, rather than the generalized transcrip-
tional activation expected upon ablation of a corepressor plat-
form protein, only a small set of transcriptional pathways was
selectively affected.
Several transcription factors control muscle differentiation and
development, including MyoD, myogenin, Myf5, Myf6, and
MEF2 (Black and Olson, 1998; McKinsey et al., 2001, 2002;
Potthoff and Olson, 2007). MEF2 especially caught our attention,
as only its expression negatively correlated with NCoR1 (Figures
4B and S6) andwas induced inNCoR1skm/muscle (Figure 6A).
MEF2 is key for muscle development and also participates in
muscle stress response and remodeling in adulthood, such as
occurs during muscle fiber type switch (Potthoff and Olson,
2007; Zhang et al., 2002). MEF2 activity is not only controlled
at the level of its expression, but also by a wide range of intracel-
lular signaling pathways and interacting coregulator molecules
(reviewed by Potthoff and Olson, 2007). The histone acetyltrans-
ferases, p300/CBP, bind, acetylate, and activate MEF2 (Ma
et al., 2005;McKinsey et al., 2001), whereas class I (HDAC3 [Gre´-
goire et al., 2007]), class II (HDAC4, 5, 7, and 9 [Haberland et al.,
2007; McKinsey et al., 2001]), and class III HDACs (SIRT1 [Zhao
et al., 2005]) all are reported to interact with MEF2 and prevent
the activation of its target genes (McKinsey et al., 2001). The
absence of NCoR1would hence favor the acetylation and activa-
tion of MEF2. The hyperacetylation of MEF2D and histone 4 in
NCoR1-deficient MEFs, C2C12 myotubes, and muscles, whichCell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 835
Figure 7. Localization and Expression of NCoR1 in Physiological Conditions
(A–C) Localization of NCoR1 protein was determined either by immunofluorescence and quantified (A and B) or by western blot (C). 293T cells grown without ()
or with (+) 1 mM insulin for 1 hr were stained by DAPI or anti-NCoR1 (A). Quantification of nuclear NCoR1 is shown in (B). Nuclear and cytosolic fractions were
separated from FLAG-NCoR1-transfected 293T cells after a 1 hr stimulation without () or with 1 mM insulin (+), and protein levels were determined by western
blotting (C).
(D) mRNA levels of NCoRs and its target genes determined by qRT-PCR in MEFs cultured for 24 hr in 5 or 25 mM glucose. n = 6.
(E) NCoR1 protein was determined by western blotting from MEFs cultured for 24 hr in 5 or 25 mM glucose.
(F) NCoR1 and SMRT mRNA were determined in MEFs cultured for 48 hr in 0, 5, and 25 mM glucose.
(G) NCoR1 protein was determined by western blotting from MEFs cultured for 24 hr in 0, 5, or 25 mM glucose.
(H) NCoR1 mRNA expression in MEFs grown for 48 hr in 0 mM glucose with or without 0.03 mM oleic acid. n = 4.
(I) NCoR1 protein determined by western blotting from MEFs cultured as indicated in (G).
(J) NCoR1mRNAmeasured by qRT-PCR in muscles of resting mice or 3 hr after an endurance run (14 weeks old; n = 5), in mice that were fed for 20 weeks either
HFD or CD (28 weeks old; n = 8), in mice that were fasted or fed for 16 hr (14 weeks old; n = 10), and in 6-month-old or 2-year-old mice (n = 10).
(K) Model schematizing how different levels of NCoR1 control transcription of muscle genes by controlling the activity of transcription factors (TFs), i.e., PPARb/d,
ERR, and MEF2.
Data are expressed as mean ± SEM. See also Figure S7 and Table S3.translates into the induction of MEF2 targets and the gain of
muscle mass in NCoR1skm/ mice, is fully in line with this idea
(Figure 6).
The increased expression of genes related to fatty acid catab-
olism and mitochondrial respiration underlies the oxidative mito-
chondrial changes observed in the NCoR1skm/ mice. In the
muscle, the expression of these gene sets is tightly controlled836 Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc.by NRs belonging to the PPAR and ERR families (Alaynick,
2008). PPARb/d, the predominant PPAR isoform in oxidative
fibers, regulates oxidative capacity and enhances slow fiber-
type function, resulting in improved exercise capacity and meta-
bolic protection (Luquet et al., 2003; Tanaka et al., 2003; Wang
et al., 2004). Among the ERRs, mainly ERRa and ERRg seem
to be involved in the coordination of muscle energy homeostasis
(reviewed in Gigue`re, 2008; Villena and Kralli, 2008). In line with
this, a genome-wide location analysis of ERRa and ERRg identi-
fied binding sites in genes of a large number of mitochondrial
proteins (Dufour et al., 2007), and studies in mouse models
show that they coordinate many aspects of muscle oxidative
metabolism, including endurance capacity (Gigue`re, 2008;
Narkar et al., 2011; Villena and Kralli, 2008). Several features
of the NCoR1skm/ mice are suggestive of the activation of
PPARb/d and ERR. The demonstration that NCoR1 is recruited
to the PPREs in the Ucp3 and the NR1/2 in Pdk4 promoters
and that histone 4 is hyperacetylated on these promoters when
NCoR1 is absent suggests that coactivators now activate the
transcription of these genes in a fashion unopposed by the
NCoR1 corepressor platform (Figure 7K). Given that PGC-1a
is a key coactivator of PPARb/d and ERR transcriptional
programs (reviewed in Handschin and Spiegelman, 2006]), it is
no surprise that several phenotypic features, ranging from
similarities in gene expression patterns over the induction of
mitochondrial oxidative metabolism and exercise capacity to
HIF1a-independent angiogenesis, are shared between mice
that lack NCoR1 or that overexpress PGC-1a (Arany et al.,
2008; Lin et al., 2002).
NCoR1 action is tightly regulated by various physiological
challenges, and this is achieved through at least two different
mechanisms. First, nuclear levels of NCoR1 are regulated. Our
results show how insulin, which stimulates glucose oxidation at
the expense of fatty acid oxidation, increases NCoR1 levels in
the nucleus, enabling it to subsequently repress lipid oxidation
genes. Interestingly, this effect of insulin on nuclear NCoR1
accumulation is consistent with the positive effect of mTORC1
on nuclear NCoR1 accumulation, recently reported in hepato-
cytes (Sengupta et al., 2010). The second mechanism involves
the modulation of NCoR1 expression. Exposing cells to media
with low glucose and/or high fatty acid levels reduces specifi-
cally NCoR1 (but not SMRT) mRNA and protein levels, ultimately
derepressing genes that control oxidative lipid metabolism.
Likewise, endurance exercise, fasting, high-fat feeding, and
aging—conditions paired with increased fat oxidation—also
are characterized by attenuated muscle NCoR1 mRNA expres-
sion. Although we are unable to detect NCoR1 protein in the
muscle with the currently available antibodies, our data in
adipose tissue unequivocally show that the specific reduction
in NCoR1 mRNA observed in that tissue after HFD is matched
with a spectacular drop in NCoR1 protein. If the reduced
NCoR1 mRNA levels in muscle also translate to corresponding
changes in NCoR1 protein, they will prime the muscle for mito-
chondrial oxidation. These selective effects of NCoR1 to repress
muscle fatty acid oxidation hence suggest that changes in
NCoR1 levels adapt transcriptional outcomes to physiological
energy needs (Figure 7K).
In conclusion, we demonstrated here that NCoR is an evolu-
tionary conserved negative regulator of both muscle mass and
mitochondrial oxidative metabolism in nematode and mammals.
In the mouse, NCoR1 achieves these effects through controlling
a rather selected set of functional pathways, which are governed
by MEF2, PPARb/d, and the ERRs. The NCoR1skm/ muscle
phenotype furthermore mirrors many features of the stimulation
of PGC-1a, a coactivator, whose action is less constrained bythe absence of the NCoR1 corepressor scaffold. Our work also
provides evidence that NCoR1 expression is regulated in
a dynamic fashion and, as such, could play a role similar
to PGC-1a in transcriptional adaptation to physiological chal-
lenges. Moreover, pharmacological inhibition of NCoR1 and/or
its interaction with deacetylases may be a viable approach to
improve muscle mass and oxidative metabolism. The fact that
the inhibition of HDACs increases muscle cell size supports
this concept (Iezzi et al., 2004). It is also tempting to spec-
ulate that the beneficial effects of the inhibition of mTORC1
and insulin signaling on health and life span may, in part, rely
on the attenuation of NCoR1 activity and the subsequent
induction of oxidative metabolism in the muscle (reviewed in
Houtkooper et al., 2010).
EXPERIMENTAL PROCEDURES
Animal Studies
NCoR1 floxed (NCoR1L2/L2), NCoR1skm+/+, and skm/mice were generated at
the Mouse Clinical Institute (Strasbourg, France) and phenotyped (Champy
et al., 2004, 2008) according to standard procedures that are described in
detail in the Extended Experimental Procedures. C. elegans strains, RNAi
feeding experiments, and GFP expression analysis are described in the
Extended Experimental Procedures. C. elegans O2 consumption was
measured in 200 2-day-old worms using a Seahorse XF24, as described in
the Extended Experimental Procedures.
Histological and EM Analyses
Staining of muscles with hematoxylin and eosin, immunohistochemical and
EM analysis, and analysis of enzymatic activity of SDH and COX were carried
out as described (Lagouge et al., 2006).
mRNA Analysis and Identification of NCoR1-Correlated Genes
The mRNA expression levels were measured in cells and tissues using
qRT-PCR (Lagouge et al., 2006) The GeneNetwork program (http://www.
genenetwork.org) was used to generate a broad range of NCoR1-correlated
genes that may contribute to the phenotype of NCoR1skm/ mice. Skeletal
muscle mRNA expression was analyzed using 124 females from a classic F2
intercross between C57BL/6J and C3H/HeJ (UCLA BHHBF2 Muscle; van
Nas et al., 2010; GEO GSE12795). NCoR1 (10024414685, 30 UTR) was
compared across all transcripts to find muscle covariates. Lung mRNA in a re-
combinant inbred intercross between C57BL/6J and DBA/2J was analyzed
across 51 strains (HZI BXD Lung M430v2 [Apr08] RMA; Alberts et al., 2011].
Four NCoR1 probe sets from this microarray were analyzed (1423200_at,
30UTR; 1435914_at, 30UTR; 1423202_a_at, exonic and 30UTR; 1423201_at,
exonic). For all probe sets, the top correlates were calculated (Tables S4
and S5). Strong or interesting correlates were selected for validation by
qRT-PCR.
Cell Culture, Adenoviral Infections, ChIP, co-IP,
and Western Blot Experiments
Experimental details are provided in the Extended Experimental Procedures.
Statistical Analyses
Statistical analyses were performed with a Student’s t test for independent
samples. Data are expressed as mean ± SEM, and p values smaller than
0.05 were considered as statistically significant. *p < 0.05; **p < 0.01; ***p <
0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and five tables and can be found with this article online at doi:10.1016/
j.cell.2011.10.017.Cell 147, 827–839, November 11, 2011 ª2011 Elsevier Inc. 837
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